Health
Research projects receive BTCA grants to develop novel drugs for various diseases – News-Medical.Net
Five research projects with exceptional promise to deliver new life-changing and health-altering therapies have received the inaugural Blavatnik Therapeutics Challenge…
Reviewed by Emily Henderson, B.Sc.Oct 30 2020
Five research projects with exceptional promise to deliver new life-changing and health-altering therapies have received the inaugural Blavatnik Therapeutics Challenge Awards (BTCA) at Harvard Medical School.
The projects, which target a diverse range of conditions–type 1 diabetes, asthma, frontotemporal dementia, deadly cancer-associated blood clots, and a rare congenital immune disease–will each receive $1 million over two years to advance their…
Continue Reading
